Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP

    NEXT STORY
    Agios to Present Updated Clinical Proof-of-Concept Data from the Phase 2 Study of Mitapivat in Thalassemia in Oral Presentation at the European Hematology Association Annual Congress
    PREV STORY
    TG Therapeutics Announces Data Presentations at Upcoming Medical Meetings
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AzurRx BioPharma Announces Successful Phase IIa Trial of MS1819-SD in Exocrine Pancreatic Insufficiency

    NEW YORK, June 29, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or ...

    author_avatar
    NASDAQ Market News

    10x Genomics to Present at the 39th Annual J.P. Morgan Healthcare Conference

    author_avatar
    NASDAQ Market News

    Saniona AB: Saniona Spin-Out, Scandion Oncology Raises DKK 2 Million and Prepares for a Potential Public Listing

    PRESS RELEASE December 19, 2017 Saniona, a leading biotech company in the field of ...

    author_avatar
    NASDAQ Market News